Jeff Yass’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Jeff Yass’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$415K	Buy	3,500 +1,000	+40%	+$108K	﹤0.01%	10337
2026 Q1	$259K	Buy	+2,500	New	+$264K	﹤0.01%	11182
2021 Q3	–	Sell	-10,800	Closed	-$869K	–	13360
2021 Q2	$869K	Sell	10,800 -34,500	-76%	-$2.74M	﹤0.01%	8159
2021 Q1	$3.57M	Buy	+45,300	New	+$3.53M	﹤0.01%	4587
2017 Q3	–	Sell	-7,300	Closed	-$458K	–	9434
2017 Q2	$458K	Sell	7,300 -1,100	-13%	-$66K	﹤0.01%	6814
2017 Q1	$494K	Buy	8,400 +3,000	+56%	+$175K	﹤0.01%	6503
2016 Q4	$303K	Buy	+5,400	New	+$311K	﹤0.01%	7951
2016 Q3	–	Sell	-5,500	Closed	-$348K	–	8885
2016 Q2	$348K	Sell	5,500 -16,100	-75%	-$1.01M	﹤0.01%	6721
2016 Q1	$1.3M	Buy	21,600 +13,100	+154%	+$801K	﹤0.01%	4566
2015 Q4	$595K	Sell	8,500 -4,800	-36%	-$340K	﹤0.01%	6436
2015 Q3	$882K	Sell	13,300 -5,600	-30%	-$436K	﹤0.01%	6032
2015 Q2	$1.48M	Buy	18,900 +6,200	+49%	+$483K	﹤0.01%	5360
2015 Q1	$970K	Buy	12,700 +1,600	+14%	+$118K	﹤0.01%	5832
2014 Q4	$738K	Buy	+11,100	New	+$739K	﹤0.01%	6458
2014 Q3	–	Sell	-3,300	Closed	-$202K	–	9815
2014 Q2	$202K	Buy	+3,300	New	+$191K	﹤0.01%	9050

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Jeff Yass's PJP Position: Q2 2026 in Review

Jeff Yass opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 4,151 shares worth $492K. The stake represents ﹤0.01% of the portfolio and ranks #9962 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PJP as recently as Q2 2025.

Jeff Yass first reported a position in PJP in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.8M in Q1 2016. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Jeff Yass held 4,151 shares of Invesco Pharmaceuticals ETF worth $492K as of Q2 2026.
Invesco Pharmaceuticals ETF was a new Jeff Yass position in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9962 holding.
Jeff Yass first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 44 quarters since.
Jeff Yass's Invesco Pharmaceuticals ETF position peaked at $4.8M in Q1 2016.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.